Paraoxonase 1 and atherosclerosis: is the gene or the protein more important?

This publication has 60 references indexed in Scilit:

• Human paraoxonase-1 gene expression by HepG2 cells is downregulated by interleukin-1β and tumor necrosis factor-α, but is upregulated by interleukin-6
  Life Sciences, 2003
• Serum paraoxonase activity in patients with type 1 diabetes compared to healthy controls
  European Journal of Clinical Investigation, 2002
• Proinflammatory Cytokines But Not Acute Phase Serum Amyloid A Or C-Reactive Protein, Downregulate Paraoxonase 1 (Pon1) Expression By Hepg2 Cells
  Amyloid, 2002
• Relationship of age-related myocardial infarction risk and Gln/Arg 192 variants of the human paraoxonase1 gene: the REGICOR study
  Atherosclerosis, 2001
• Effect of Gemfibrozil on HDL-Associated Serum Paraoxonase Activity and Lipoprotein Profile in Patients with Hyperlipidaemia
  Clinical Drug Investigation, 2000
• Paraoxonase Activity Is Reduced by a Pro-atherosclerotic Diet in Rabbits
  Biochemical and Biophysical Research Communications, 2000
• Low paraoxonase activity in type II diabetes mellitus complicated by retinopathy
  Clinical Science, 2000
• Paraoxonase polymorphisms are not associated with cardiovascular risk in renal transplant recipients
  Kidney International, 1999
• Human Serum Paraoxonase
  General Pharmacology: The Vascular System, 1998
• Paraoxonase-2 Gene (PON2) G148 Variant Associated with Elevated Fasting Plasma Glucose in Noninsulin-Dependent Diabetes Mellitus
  Journal of Clinical Endocrinology & Metabolism, 1997